October 1, 2024

Supplementary Figure S4 from Tyrosine Protein Kinase SYK-Related Gene Signature in Baseline Immune Cells Associated with Adjuvant Immunotherapy–Induced Immune-Related Adverse Events in Melanoma

View Full Paper

Ask AI

Bookmark

Abstract

Supplementary Figure S4. Semi-supervised hierarchical clustering of the DEGs comparing TOXlow vs TOXhighin CD4+ cells from NIVO-treated patients (n = 124) identified from PPI analysis.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Monson et al. (2024) studied this question.

synapsesocial.com/papers/68e56226e2b3180350efef2c https://doi.org/10.1158/1078-0432.27142339

View Full Paper

Ask AI

Bookmark

Abstract

Supplementary Figure S4. Semi-supervised hierarchical clustering of the DEGs comparing TOXlow vs TOXhighin CD4+ cells from NIVO-treated patients (n = 124) identified from PPI analysis.

Supplementary Figure S4 from Tyrosine Protein Kinase SYK-Related Gene Signature in Baseline Immune Cells Associated with Adjuvant Immunotherapy–Induced Immune-Related Adverse Events in Melanoma

Abstract

Discussion

Cite This Study

Supplementary Figure S4 from Tyrosine Protein Kinase SYK-Related Gene Signature in Baseline Immune Cells Associated with Adjuvant Immunotherapy–Induced Immune-Related Adverse Events in Melanoma

Abstract

Discussion

Cite This Study

Keep reading

Keep reading